Self-assembling peptide scaffold
AssigneeHexamer Therapeutics, Inc.
InventorKeith Douglas Miller
Life of this patent
Estimating the term…
Abstract
The present disclosure describes a peptide scaffold for producing vaccines. The peptide scaffold includes a peptide that self-assembles into a hapten carrier (hC) includes amphipathic alpha-helices. The peptide includes heptad repeats following a specific pattern. The hC further includes hapten or an agent conjugated to it, and optionally the hC includes one or more T-cell epitopes at the N- and/or C-terminus of the one or more amphipathic alpha-helices. The present disclosure also describes compositions including immunogenic compositions including the hapten-hC or agent-hC conjugate.
Claims4
A method of protecting a subject from a disease, wherein the method comprises administering to the subject in need thereof, an effective amount of a peptide conjugate comprising an oligomer and one or more haptens, wherein the hapten induces an immune response to protect a subject from the disease, and wherein the oligomer comprises a peptide comprising one or more heptads:
- wherein the heptad has the following amino acid sequence:
- hwxhxyz (SEQ ID NO:
- 19;
- wherein the peptide comprises the following amino acid sequence pattern:
- (SEQ ID NO:
- 20)
- (hwxhxyz)n,
- and wherein:
- h is I, L, V, F, W, Y, M, W, G, or A;
- w is G, R, A, N, Q, H, S, D, E, K or T;
- x is R, S, N, Q, A, G, T, D, E, K, H, or C;
- y is K, H, C, D, E, R, W, Y, Q, N, or a non-natural amino acid or molecule containing reactive groups amenable to covalent coupling;
- z is A, D, H, S, E, R, N, Q, K, or G;
- and
- n is 2 to 10.
A method of treating a subject having a disease, wherein the method comprises administering to the subject in need thereof, an effective amount of a peptide conjugate comprising an oligomer and one or more haptens, wherein the hapten induces an immune response to treat the subject and wherein the oligomer comprises a peptide comprising one or more heptads:
- wherein the heptad has the following amino acid sequence:
- hwxhxyz (SEQ ID NO:
- 19;
- wherein the peptide comprises the following amino acid sequence pattern:
- (SEQ ID NO:
- 20)
- (hwxhxyz)n,
- and wherein:
- h is I, L, V, F, W, Y, M, W, G, or A;
- w is G, R, A, N, Q, H, S, D, E, K or T;
- x is R, S, N, Q, A, G, T, D, E, K, H, or C;
- y is K, H, C, D, E, R, W, Y, Q, N, or a non-natural amino acid or molecule containing reactive groups amenable to covalent coupling;
- z is A, D, H, S, E, R, N, Q, K, or G;
- and
- n is 2 to 10.
Dependencies are inferred from the claim text.